A Clinical Stage Immuno-Oncology Company with a Growing Late-Stage Pipeline

Learn More

Executive Summary

Predictive Therapeutics is a clinical stage oncology company, with a focus on immunotherapy. We seek to acquire undervalued late stage assets for clinical development. Our goal is to unlock the potential of these promising cancer therapies in order to bring effective and safe drugs to patients.

Management

Asher Nathan

ASHER NATHAN PhD

CEO

Dr. Asher Nathan has extensive biotech operating experience, having started biotech companies, Intelligene and ...

Read more
Marcel Rozencweig M.D.

MARCEL ROZENCWEIG M.D.

CMO

Dr. Rozencweig is a medical oncologist with more than 40 years of experience and accumulated expertise in clinical trials and...

Read more
Ramona Lloyd PhD

RAMONA LLOYD PhD R.A.C.

COO

Dr. Lloyd is a leading regulatory expert with over 20 years of experience in global regulatory affairs and quality assurance. ...

Read more
Robert Harow

ROBERT HAROW

CFO

Prior to co-founding Predictive Therapeutics, Mr. Harow co-founded Zoticon Bioventures, where ...

Read more
Roger Kornberg PhD

ROGER KORNBERG PhD

CSO

Dr. Kornberg was awarded the Nobel Prize in Chemistry in 2006 for his studies of the process by which genetic information ...

Read more
Dr. Michal Shahar

MICHAL SHAHAR PhD

VP of R&D

Dr. Shahar previously served as VP of Research and Development at Efranat Ltd., an immuno-oncology drug ...

Read more

Pipeline

Predictive Therapeutics is building a late-stage pipeline of differentiated cancer therapies

PT101: Immunotherapy
PT101 coats tumor cells with molecules which direct the patient’s immune system against the tumor.
PT101 has been through Phase III clinical development with acceptable safety
View Press Release

NEWS

October 2015
Predictive Therapeutics closes $2,500,000 Series A funding

Predictive Therapeutics, a Precision Medicine drug development company, has raised over $2,500,000 in Series A funding.

Biotech entrepreneur CEO, Dr. Asher Nathan, stated "I am extremely proud of the high quality senior management team we have been able to attract, and the faith that our Series A investors have placed in our ability to succeed. We are extremely excited by the steps we have been able to accomplish early in our existence."

Contact Us

Predictive Therapeutics Ltd.
2 Pekeris Street
Rehovot, Israel
Phone: +1 609 718 2305
Phone: +972 3 912 5853
Fax: +972 8 936 8584

Contact Predictive Therapeutics

Copyright Predictive Therapeutics Ltd. © 2016 | All Rights Reserved